USPTO serial 87983383
THE HUMAN DATA SCIENCE COMPANY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 13, 2020
- Examiner
- EINSTEIN, MATTHEW T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with THE HUMAN DATA SCIENCE COMPANY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $2,125
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Parsippany, NJ, US
PARSIPPANY, NJ, US
PARSIPPANY, NJ, US
PARSIPPANY, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Johnson Walden
Cynthia Johnson Walden FISH & RICHARDSON P.C.P.O. Box 1022MINNEAPOLIS, MN 55440-1022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Market analysis and research services; Business market consulting; Marketing consulting; Business consulting and information services; Business consulting services and business management consulting in the pharmaceutical, medical, healthcare, and life sciences fields; Business process outsourcing services in the pharmaceutical, medical, healthcare, and life sciences fields; Providing a web-based online portal that provides customer access to business information in the fields of pharmaceutical, medical, healthcare, and life sciences; Public policy research services; Computerized database management and data processing services in the pharmaceutical, medical, healthcare, and life sciences fields; Sales representatives in the pharmaceutical, medical, healthcare, and life sciences fields; Business consultation and management regarding marketing activities, launching of new products and services, and sales; Personnel recruitment and placement; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; Providing independent review of clinical trials for business purposes; Maintaining a registry of patients, namely, compilation of patient information into computer databases; Business consulting and business management consultation services related to healthcare management and electronic health records (EHR) management; Business management consulting and advisory services in pharmaceutical, medical, healthcare, and life sciences fields; Advertising, marketing and promotional services in the pharmaceutical, medical, healthcare, and life sciences fields; Business management services, namely, quality management services of patient-care programs; Recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of drugs, biologics and devices; Business consulting in the fields of healthcare management | ACTIVE | — |
| 041 | Education and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the pharmaceutical, medical, healthcare, and life sciences fields; Educational and training services, namely, conducting conferences to train physicians and other medical providers on conducting clinical trials; Education and training services, namely, providing non-downloadable webinars, webcasts and digital content in the pharmaceutical, medical, healthcare, and life sciences fields; Non-downloadable online publications in the nature of brochures, reports, or white papers in the pharmaceutical, medical, healthcare, and life sciences fields | ACTIVE | — |
| 042 | Providing online, non-downloadable software for providing pharmaceutical, medical, healthcare, and life sciences information and analysis; Software as a service (SAAS) services featuring software for providing, collecting, analyzing pharmaceutical, medical, healthcare, and life sciences information; Computer services, namely, providing on-line, non-downloadable computer software used for accessing, collecting, managing, tracking, analyzing, and reporting data in the pharmaceutical, medical, healthcare, and life sciences fields; Research and analysis related to pharmaceutical, medical, healthcare, and life sciences information; Computer services, namely, designing, developing and managing application software and databases related to pharmaceutical, medical, healthcare, and life sciences information; Computer software development for others; Clinical research, clinical testing, and laboratory testing services in the pharmaceutical, medical, healthcare, and life sciences fields; Product development consultation in the pharmaceutical, medical, healthcare, medical and life sciences fields; Conducting clinical trials for others; Providing temporary use of on-line non-downloadable software for use in healthcare and electronic health record (EHR) management; Information technology consulting services; Computer software consultation services in the pharmaceutical, medical, healthcare, and life sciences fields; Scientific research in the pharmaceutical, medical, healthcare, and life sciences fields; Computer services, namely, creating computer network-based indexes and databases of information; Providing electronic data capture (EDC) and management systems, namely, providing temporary use of online, non-downloadable software for collection and management of healthcare and life sciences data; Non-downloadable computer software for collecting, managing, and analyzing clinical trial data; Providing an on-line interactive database featuring information in the pharmaceutical, medical, healthcare, and life sciences fields; Providing information relating to the development, validation, and regulatory approval of drugs, biologics and devices | ACTIVE | — |
| 044 | Providing pharmaceutical, medical, healthcare, and life sciences information to others | ACTIVE | — |
| 045 | Regulatory compliance legal research in the field of design and development of drugs, devices, biologics and methodologies used in the pharmaceutical industry, and medical industry; Regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields; Providing regulatory information, namely, legal information regarding compliance with pharmaceutical, medical, healthcare, and life sciences fields regulations; Providing regulatory implementation services relating to the development, validation, and production of drugs, biologics and devices; Providing an online, interactive computer database in the field of regulatory affairs relating to the pharmaceutical, medical, healthcare, and life sciences fields | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Quintiles IMS Incorporated
- Other trademarks owned by IQVIA INC.
- Other trademarks owned by IQVIA INC.
- Other trademarks owned by IQVIA INC.
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named THE HUMAN DATA SCIENCE COMPANY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 13, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 13, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 10, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 9, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 24, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 24, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Aug 3, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 25, 2020 | IUAF | USE AMENDMENT FILED | — |
| Jun 25, 2020 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jun 25, 2020 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jun 25, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 17, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 15, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 15, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 15, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 6, 2019 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Dec 26, 2018 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 27, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 27, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 7, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 18, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 17, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2018 | ALIE | ASSIGNED TO LIE | — |
| Mar 1, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 1, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 21, 2017 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 7, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2017 | NWAP | NEW APPLICATION ENTERED | — |